Cohance Lifesciences Ltd Stock News

Cohance Lifesciences Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹449.85
-4.00(-0.88%)
As on 23 Oct 2026 at 15:58
As of 23 Oct 2026 at 15:58, Cohance Lifesciences Ltd is trading at ₹449.85. The 52-week range stands at ₹266.70–₹903.40, with a market cap of ₹17.17 thousand crore. At a P/E of 89.73 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.

COHANCE Price Chart

Market Cap
₹17.17K Cr
PE Ratio
89.73
ROCE
7.27%

Cohance Lifesciences Ltd Latest News

View More
07 OCT 2026 | Wednesday
Cohance Lifesciences files certificates with BSE and NSE, complying with SEBI regulations
28 SEPT 2026 | Monday
Cohance Lifesciences halts trading for insiders pending financial results declaration
03 SEPT 2026 | Thursday
Cohance invests USD 5 million in Aruka Bio, securing approximately 65% ownership
13 AUG 2026 | Thursday
India Ratings affirmed IND3+ rating on Rs 500 crore bank loans and IND2 rating on Rs 200 crore debentures
24 JUL 2026 | Friday
Cohance Lifesciences to table results
23 JUN 2026 | Tuesday
Volumes spurt at Cohance Lifesciences Ltd counter
23 JUN 2026 | Tuesday
Cohance Lifesciences Ltd leads gainers in 'A' group
23 JUN 2026 | Tuesday
Volumes soar at Cohance Lifesciences Ltd counter
18 JUN 2026 | Thursday
Cohance Lifesciences CFO Himanshu Agarwal resigns to pursue opportunity outside company
07 MAY 2026 | Thursday
Cohance Lifesciences to discuss results

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now